Evidence map›Paper›PMID 38974301›Full record

ReviewAfrican health sciences2023

Isoniazid hair drug levels among TB patients as a tool to monitor adherence, exposure, and TB treatment outcomes and its acceptability in a multicultural setting. A narrative review.

Grace Muzanyi, Muhammad Ntale, Robert Salata, Moses Joloba, Jackson Mukonzo, David Mafigiri, Paul Mubiri, Godfrey Bbosa

Abstract readReview
In one paragraph

Review in African health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grace MuzanyiDepartment of Pharmacology and Therapeutics, Makerere College of Health Sciences.
Muhammad NtaleDepartment of Chemistry, College of Natural Sciences, Makerere University.
Robert SalataUganda-Case Western Reserve University Research Collaboration.
Moses JolobaUganda-Case Western Reserve University Research Collaboration.
Jackson MukonzoDepartment of Pharmacology and Therapeutics, Makerere College of Health Sciences.
David MafigiriUganda-Case Western Reserve University Research Collaboration.
Paul MubiriMakerere University School of Public Health.
Godfrey BbosaDepartment of Pharmacology and Therapeutics, Makerere College of Health Sciences.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accumulation of chemicals including drugs in hair has been used in forensic investigations. Studies have reported isoniazid drug levels in the hair of TB patients. Objective: To review literature for evidence on isoniazid hair drug levels as a tool to monitor adherence, exposure, and TB treatment outcomes and the acceptability of using human hair for medical testing. Methods: We reviewed literature through Pubmed, Embase, Medline, google scholar, and google grey literature. The search terms focused on isoniazid/TB hair drug levels, adherence, treatment outcomes, and acceptability of using hair for medical testing. We kept refining our search terms at each step of our search. Results: The initial search yielded 186859 articles, which dropped to 88 after removing duplicates and irrelevant articles and eventually to 14 on further refining our search terms. On full review,2 out of 14 and 1 out of 14 articles touched the area of Isoniazid hair drug levels; adherence, exposure, TB treatment outcomes, and acceptability respectively. Further scrutiny showed that none of the articles had addressed our research question. Conclusion: Literature on Isoniazid hair drug levels among TB patients as a tool to monitor adherence, exposure, and TB treatment outcomes, and its acceptability is limited and more research is needed.

Indexed as

Antitubercular AgentsHairIsoniazidTuberculosisDrug MonitoringHumansTreatment OutcomeAntitubercular AgentsIsoniazidadherencemulticultural settingnarrative reviewTB patientsTB treatment outcomes

Identifiers

PMID38974301
PMCPMC11225455

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.